ICD-10: | R97.2 |
---|---|
Short Description: | Elevated prostate specific antigen [PSA] |
Long Description: | Elevated prostate specific antigen [PSA] |
Z12.5Report HCPCS Level II code G0102 Prostate cancer screening; digital rectal examination or G0103 Prostate cancer screening; prostate specific antigen test (PSA), total, as appropriate, with ICD-10-CM diagnosis code Z12. 5 Encounter for screening for malignant neoplasm of prostate (ICD-9-CM V76.Sep 28, 2015
Submit HCPCS code G0103 for screening PSA tests : EPIC: LAB2683 • Medicare coverage for screening PSAs is limited to once every 12 months Diagnostic PSAs • CPT codes for diagnostic PSA tests are 84153 : EPIC: LAB4427 TIP: Free and Total PSA is a diagnostic PSA and should be coded as such.
Rising PSA following treatment for malignant neoplasm of prostate. R97. 21 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
C61: Malignant neoplasm of prostate.
The PSA test is a blood test used primarily to screen for prostate cancer. The test measures the amount of prostate-specific antigen (PSA) in your blood. PSA is a protein produced by both cancerous and noncancerous tissue in the prostate, a small gland that sits below the bladder in males.Jun 22, 2021
Medicare Part B pays for one prostate cancer screening test each year. You pay no out-of-pocket cost for a PSA test if your doctor accepts Medicare assignment, and the Part B deductible does not apply. Medicare Advantage plans also cover a yearly PSA test. Check with your plan for coverage details.
Elevated prostate-specific antigen (PSA) levels can be a sign of prostate cancer. It can also indicate noncancerous problems such as prostate enlargement and inflammation.Apr 6, 2021
288.60 - Leukocytosis, unspecified. ICD-10-CM.
Secondary malignant neoplasm of genital organs C79. 82 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C79. 82 became effective on October 1, 2021.
51: Secondary malignant neoplasm of bone.
R97.2 is a non-billable ICD-10 code for Elevated prostate specific antigen [PSA]. It should not be used for HIPAA-covered transactions as a more specific code is available to choose from below.
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically.